Key facts
- This page summarizes ELI LILLY & Co's Form 3 filing for Lycia Therapeutics, Inc..
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 22 Oct 2026, 21:37.
Key filing fact
Ownership activity is grounded in SEC Form 3 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
No transaction description listed
Additional SEC filing notes
Footnote F1
The reported securities represent shares of Common Stock issuable upon mandatory conversion of convertible preferred stock in the Issuer's initial public offering but do not include shares of Common Stock purchased in the initial public offering, as such amount was not known at the time of this filing. See Remarks below.
SEC remarks
After giving effect to the closing of the Issuer's initial public offering, including the Reporting Person's purchase in such offering, the Reporting Person will cease to be a 10% Owner and, accordingly, will have no further Section 16 reporting obligations.